| 000 | 01689 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516060059.0 | ||
| 264 | 0 | _c20111122 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Shali | |
| 245 | 0 | 0 |
_aFluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways. _h[electronic resource] |
| 260 |
_bAnticancer research _cOct 2011 |
||
| 300 |
_a3259-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnthracenes _xpharmacology |
| 650 | 0 | 4 |
_aBenzenesulfonates _xpharmacology |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aChromones _xpharmacology |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aFatty Acids, Monounsaturated _xpharmacology |
| 650 | 0 | 4 | _aFluvastatin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aMelanoma _xenzymology |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSorafenib |
| 700 | 1 | _aDoudican, Nicole A | |
| 700 | 1 | _aQuay, Ellinor | |
| 700 | 1 | _aOrlow, Seth J | |
| 773 | 0 |
_tAnticancer research _gvol. 31 _gno. 10 _gp. 3259-65 |
|
| 999 |
_c21202104 _d21202104 |
||